Iverheal 3 mg

When prescribed for an infection that responds to ivermectin, Iverheal 3 mg can:

• Reduce the number of susceptible parasites

• Help control infection-related symptoms

• Prevent the infection from continuing to progress

• Provide a smaller strength for accurate weight-based dosing

• Support treatment when a higher-strength tablet is unsuitable

The treatment benefit depends on identifying the correct parasite and taking the complete prescribed dose. Some infections require follow-up testing or a repeat treatment schedule.

Ivermectin attaches to specific chloride channels in the nerve and muscle cells of susceptible parasites. This increases chloride movement into these cells and interferes with normal nerve signals.

The affected parasites become paralysed and die or are gradually removed from the body. Ivermectin only works against parasites that are sensitive to it; it does not treat every worm, skin condition, bacterial infection or viral illness.

Iverheal dosage is calculated according to body weight, diagnosed infection, treatment guidelines and individual health factors. The 3 mg strength allows the prescribed total dose to be assembled using smaller tablet units.

For context, ivermectin is commonly prescribed at approximately 200 micrograms per kilogram for uncomplicated strongyloidiasis and 150 micrograms per kilogram for onchocerciasis. These are general medical dosing references and should not be used to calculate a personal dose without a prescription.

Take the prescribed tablets together with water, following the instructions given by the healthcare professional. Many oral ivermectin labels direct patients to take the dose on an empty stomach. Treatment schedules for scabies and other off-label uses can differ and sometimes include a second dose after a specified interval.

There is no established Iverheal 3 mg dosage for COVID-19 or cancer, as the clinical trials are still ongoing. Doses used in research studies should never be copied for self-treatment.

Common Side Effects: Iverheal 3 mg can cause nausea, diarrhoea, abdominal discomfort, dizziness, headache, weakness, itching, rash or mild swelling. Some symptoms can result from the body reacting to dying parasites. Contact the prescriber if these effects persist, worsen or interfere with normal activities.

Serious Side Effects: Seek urgent medical help for breathing difficulty, facial or throat swelling, severe or blistering rash, fainting, confusion, seizures, difficulty walking, extreme sleepiness, significant vision changes or yellowing of the skin or eyes. People with a heavy Loa loa infection can develop a rare but serious neurological reaction after ivermectin treatment.

Medical assessment is especially important for:

• People allergic to ivermectin

• Children weighing below 15 kg

• Pregnant or breastfeeding women

• People with significant liver problems

• People at risk of Loa loa infection

• People taking warfarin

• People using sedating medicines

• People considering it for COVID-19

• People considering it for cancer self-treatment

Tell the healthcare professional about every medicine, supplement and herbal product being used. Important interactions requiring review include:

• Warfarin and other anticoagulants

• Sedatives or sleeping medicines

• Certain antifungal medicines

• Macrolide antibiotics

• HIV protease inhibitors

• Anti-seizure medicines

• Other antiparasitic treatments

• Chemotherapy or immunotherapy medicines

Warfarin users can require additional blood-clotting checks. Do not combine ivermectin with another treatment or repeat the dose without professional instructions.

• Store below 30°C.

• Keep the tablets in their original strip.

• Protect them from heat and moisture.

• Keep away from direct sunlight.

• Store out of reach of children and pets.

• Do not use damaged or discoloured tablets.

• Do not use the medicine after its expiry date.

• Follow local guidance when disposing of unused tablets.